The Diagnosis and Management of Cutaneous Metastases from Melanoma

Cosimo Di Raimondo1, Flavia Lozzi1, Pier Paolo Di Domenico1

  • 1Department of Dermatology, University of Roma Tor Vergata, 00133 Rome, Italy.

Insights

Melanoma skin metastases are common in advanced disease. Further research into their pathogenesis is needed to improve patient outcomes despite current therapies.

Area of Science:

  • Oncology
  • Dermatology
  • Cancer Research

Background:

  • Melanoma is a deadly skin cancer, causing most skin cancer deaths.
  • Advanced melanoma treatments like immunotherapy have improved prognoses, but disease progression remains a challenge for many patients.
  • Cutaneous (skin) metastases are frequent in advanced melanoma, signaling recurrence or advanced disease.

Purpose of the Study:

  • To review the clinical presentation and management of melanoma skin metastases.
  • To highlight the need for further research into the molecular mechanisms of melanoma metastasis to the skin.
  • To understand the varying behaviors and prognoses associated with cutaneous melanoma metastases.

Main Methods:

  • This review synthesizes current knowledge on melanoma skin metastases.
  • It discusses existing treatment modalities, including surgery, local therapies, and systemic treatments.
  • It emphasizes the importance of ongoing research into the pathogenesis of these metastases.

Main Results:

  • Melanoma skin metastases can be asymptomatic or cause local symptoms like ulceration or bleeding.
  • They often indicate advanced disease or recurrence.
  • Current treatments are diverse, ranging from local interventions to systemic therapies.

Conclusions:

  • Despite advances in melanoma treatment, understanding cutaneous metastases is crucial.
  • Further investigation into the pathogenesis and molecular mechanisms of skin metastases is essential.
  • This research may elucidate factors influencing different patient prognoses and treatment responses.

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.2K
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
3.9K
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
2.0K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K